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Chitosan-based Multicomponent Remedy in Patients
with Acantholytic Lesion of the Tissues of the




The article describes the offered by us multicomponent remedy based on chitosan, to provide analgesic and wound-healing
effect in patients with acantholytic lesions of the prosthetic bed tissues.
Objective of the study. To improve the conditions of removable dentures use for patients with acantholytic pemphigus.
Materials and methods. The study involved 56 patients with acantholytic pemphigus, aged from 45 to 63 years old, who
were divided into 2 clinical groups. The main group used the proposed remedy; the comparative group received the standard
local pemphigus treatment. Methods for determining the area of mucus lesion and the method for determining the intensity of
pain syndrome were used to evaluate the final results.
Results of the study and their discussion. The average value of visual analogue scale (VAS) was 4.76±0.56 cm in
patients of the main group during the first day. During the 7th and 14th day, the value decreased to 2.4±0.28 cm and
1.87±0.12 cm, respectively. In patients of the comparison group, the average value of VAS was 5.07±0.36 cm as for the first
day and 4.45±0.45 and 2.36±0.17 cm during the 7th and 14th days, respectively. The ratio of the mean value of the affected
area in patients of the main group and the comparison group was 1.04 during the first day, and during the 7th and 14th day
the area of injury in patients of the main group was lower 1.29- and 1.84-fold, respectively.
Conclusions. The results of the study confirm the necessity of using a multicomponent remedy based on chitosan together
with the removable dentures in patients with acantholytic pemphigus, due to its clearly expressed epithelial and analgesic
action.
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Problem statement and analysis of the
latest research
In the middle of the last century, it was noted that adding of
some polymers to the dosage forms increases the time of their
income on the surface of the mucous membrane and increases
the effectiveness of therapy [4]. With the development of the
theory of mucoadhesion and the improvement of practical
methods, many polymers allowed for the use in pharmacy, as
well as new materials and their mixtures, were studied for the
presence of mucoadhesive properties. Mucoadhesive polymer
(MAP) should be characterized by certain physical-chemical
properties, including hydrophilicity, a large amount of groups
capable of forming hydrogen bonds, the mobility of chains,
sufficient for diffusion, both through mucus and epithelial
tissue [7]. The ability to drain water from the surface of the
mucous membranes in dry form leads to a strong initial inter-
action [6]. When moisturized, MAP forms viscous substances,
which increases the time of their stay on the surface of the
mucous membrane and promotes the appearance of adhesive
interactions.
Studies are focused on the development of mucoadhe-
sive systems that create contact with the surface due to Van
der Waals interactions and hydrogen bonds. Although these
strengths are weak, a sufficiently strong adhesion is achieved
through the formation of numerous contacts.
Therefore, polymers of high molecular weight and a large
number of polar groups (COOH and OH) are characterized by
stronger mucoadhesion with minimal toxicity. To date, chi-
tosan is the only mucoadhesive polymer possessing positively
charged groups with proven absence of toxicity [9].
Chitosan (2-amino-2-deoxy-β -D-glucan) is a polymer ob-
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tained from the component of the exoskeleton of arthropods –
chitin by partial or complete deacetylation. This polysaccha-
ride is characterized by pronounced immunotropic action, as
well as antibacterial, antioxidant, detoxicate, analgesic and
wound-healing ability [1, 6].
Chitosan can serve as a precursor to a number of gly-
cosaminoglycans, chondroitin-4-sulfate, chondroitin-6-sulfate,
keratan-sulfate, hyaluronic acid, which are involved in the for-
mation and metabolism of tissues, including bones, cartilage
and mucous membrane. Chitosan is harmless in the toxic way.
It has good biocompatibility with tissues of living organisms,
biodegradability, and pronounced sorption properties [5, 9].
The study of the use of a multicomponent remedy (gel,
paste) on the basis of chitosan in the clinic of orthopedic
dentistry will allow someone to improve the adaptation to
the removable prosthetics of patients with pemphigus with
acantholytic lesion of the prosthetic bed tissues, by reducing
the pain sensation that occurs through the contact of the pros-
thetic base and the affected areas, prevention the emergence
of a distant symptom of Nikolsky as a result of mechanical
irritation of the unaffected areas of the mucous membrane of
the prosthesis and the acceleration of the epithelization and
reduction of the area of mucous membrane erosions. The
above-mentioned effect is possible due to such properties of
the offered by us remedy as mucoadhesion, local anesthetic
and wound-healing effect. The use of this remedy creates a
buffer between the prosthesis and the prosthetic bed, which
helps significantly reduce the effect of the prosthesis base onto
the mucous membrane.
1. Materials and Methods
The patients were divided into 2 clinical groups: the main
group and the comparison group. The main group included
28 patients with acantholytic pemphigus aged 45 to 63 who
use removable dentures. These patients have used the remedy
offered by us: water-insoluble colloidal solution of chitosan
(4%) and anesthetic was applied by thin layer onto the surface
of the base of removable laminar denture, after which the
patients were offered to use this construction.
The group of comparison included 28 patients with acan-
tholytic pemphigus, aged 45 to 63 years, who use the remov-
able dentures. They were performed a common local therapy
of acantholytic lesions on the mucous membrane.
To evaluate the final results, we have used the method
to determine the area of mucous lesions and the method for
determining the intensity of pain syndrome.
Determination of the area of lesions of MMOC using the
modified method of O.S. Gileva (according to Nurieva N.S.)
The method used to determine the area of damage of the
mucous membrane of the oral cavity (MMOC) and the red
border of the lips by the authorship of the prof. Gileva O.S.
involves the use of sterile rubbers. When using this method
the area of lesion is defined using the circling of defects with
chemical pencil, imposing on them sterile rubbers and moving
the reflection of contour from the rubber onto the reference
grid, followed by manual counting of damaged area using the
formula S = m2 1 + m2 2 + m2 3 + m2 4 / n, where m21,
m22, m23, m24 – the sum of all areas of erosions on the inner
surface of the cheeks (1), mouth (2), gums (3) and the lips (4),
n – number of measurements.
The modified method (according to Nurieva N.S.) involves
the use of silicone imprint masses instead of rubbers. Such a
method is more practical in dental practice, and allows you to
more easily and accurately copy the contour of the element
of lesion. We, in turn, offer to abandon the use of chemical
pencils, because of the possibility of allergic reactions in
patients, and additional irritation of element of the damage.
To indicate the contour of the lesion, we used a correction
mass, which was administered using the applicator [3].
The evaluation of the pain syndrome was performed using
the visual analogue scale (VAS) (assessed by the subjective
sensation of pain intensity) (Visual Analogue Scale (VAS)
(Huskisson E. C., 1974) . This method of subjective evaluation
of pain consists in the fact that the patient is asked to mark a
point that corresponds to the severity of pain on a non-graded
line of 10 cm long. The left border of the line corresponds to
the definition of ”0” (absence of pain), the right one – ”10”
(pain is unbearable). As a rule, they usually use a paper,
cardboard or plastic ruler 10 cm long. On the reverse side of
the ruler there are centimeter divisions, in which the doctor
notes the acquired value and enters it into the observation
checklist. An unequivocal benefit of this scale is its simplicity
and convenience. When dynamically evaluated, the change
in pain intensity is considered to be objective and significant
if the true value of VAS is different from the previous one
more than at 13 mm. The visual analogue scale reflects the
intensity of pain experienced by the patient at the moment
of the examination. The pain intensity is marked by patient
himself/herself.
The examination complex was performed three times dur-
ing the period of exacerbation of the acantholytic pemphigus,
and its manifestations on the mucous membrane: during the
1st, 7th, 14th days.
The data was processed using Statistica software. The cri-
terion for statistical reliability was considered to be the value
of p≤0.05, where p – is the level of statistical significance.
2. Results and Discussion
Having analyzed the results of the study, we obtained the
following data. The average value of VAS was 4.76±0.56
cm in patients of the main group during the first day. During
the 7th and 14th days the value decreased to 2.4±0.28 cm and
1.87±0.12 cm, respectively. In patients of the comparison
group, the average value of VAS was 5.07±0.36 cm as of the
first day and 4.45±0.45 and 2.36±0.17 during the 7th and 14th
days, respectively. As it can be seen from the given diagrams
(Fig. 1, 2), in the main and the comparison groups the indeces
of VAS (visual analogue scale) and area of the damage tended
to decrease.
Comparative Evaluation of the Use of a Chitosan-based Multicomponent Remedy in Patients with Acantholytic
Lesion of the Tissues of the Prosthetic Bed to Provide Conditions for the Use of Removable Dentures — 3/4
Figure 1. Dynamics of VAS indeces
This is logically due to the strengthening of total gluco-
corticosteroid therapy, and the reduction of manifestations of
exacerbation symptoms. However, we observe a significant
decrease of the damage area in the main group during the 7th
and 14th day, which in turn leads to a decrease of the intensity
of pain sensation while using the removable dentures in pa-
tients of the main group. The ratio of the average value of the
affected area in patients of the main and comparison groups
was 1.04 during the first day, and during the 7th and 14th days
the area of injury in patients of the main group was lower at
1.29 and 1.84 times, respectively.
This therapeutic effect is possible due to the mucoadhesion
of the offered by us remedy, which provides longer analgesic
and wound healing action and the ability to significantly re-
duce the negative mechanical impact of the prosthesis base on
the mucous membrane.
3. Conclusions
The use of a chitosan-based multicomponent remedy (gel,
paste) is necessary in patients with acantholytic pemphigus
with acantholytic damage of tissues in patient using removable
dentures, since it provides faster epithelization of erosion
than conventional local therapy, reduces pain sensation during
dentures’ use, which in turn improves the general condition of
the patient, facilitates its adaptation to removable prosthesis. It
is planned to expand the scope of further research to establish
the most effective algorithm for the combined use of offered
by us means and removable dentures in different conditions:
during meals, conversations, in a state of rest, for the provision
of the ability of patients with acantholytic damage of tissues of
the prosthetic bed to use qualitatively the removable dentures.
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